Anderson and co-workers' recently described a simple high-performance liquid chromatographic/fluorimetric assay for serotonin and tryptophan. in which deproteinised samples were directly injected. Using this method routinely. we frequently observed interference which could not sufficiently be resolved from serotonin to allow accurate quantitation. However, when the amine was isolated by ion-exchange chromatography prior to HPLC separation as advocated by Koch and Kissinger.i chromatograms were obtained with practically no extraneous peaks. In this paper the application of this method for the determination of serotonin in CSF, plasma, serum and urine is described.
The biogenic amine serotonin is mainly present in the enterochromaffin cells of the intestine, in serotonergic neurons in the brain and in platelets. It functions as a neurotransmitter or a vasoconstrictor and thus its determination in biological fluids can be of diagnostic value in certain mental disorders (e.g. autism, depression, Down's syndrome, schizophrenia), in carcinoid tumours of the intestine or in viability studies of platelets.
In the detection of carcinoid tumours the determination of urinary 5-hydroxyindole acetic acid is the method of choice, while in other cases the determination of serotonin itself in plasma, serum, urine or cerebrospinal fluid (CSF) can be of use.
Materials and methods

CHEMICALS
The standards 5-hydroxytryptamine (5-HT, serotonin) and 5-methoxytryptamine (5-MT, internal standard) were purchased from Aldrich-Europe, Beerse, Belgium; the weak cation-exchange resin Amberlite-CG-50, from Mallinckrodt Chemical Works, St Louis, USA; sodium lauryl sulphate (SDS) from BDH Chemicals Ltd, Poole, England. All other chemicals were of analytical grade and obtained from Merck, Darmstadt, FRG.
INSTRUMENTATION AND HPLC
CONDITIONS
A Spectra Physics SP H700 solvent delivery system (Spectra Physics. Autolab Division, San Jose, USA) was used to deliver the solvent through a 10 cmx4·6 mrn, RP-IH Spheri-S IJ-m column (Brownlee Labs lnc., Santa Clara. USA) at a flow rate of 1·0 ml per minute. Samples were introduced through a 200-IJ-I loop attached to a conventional injection valve (Rhcodyne , Berkeley, USA. Model 7 (10) . Effluent was monitored with a Model 650-IOS scanning tluorescence spectrophotometer (Perkin Elmer Corporation. Norwalk. USA). Detection of endogenous fluorescence was performed by excitation at 2YO nm and emission at 33H nm. The ion-pairing solvent system was prepared by mixing 3S0 ml methanol and 60 ml acetonitrile with SYO ml of a solution of sodium acetate (1) .(IHS mol/l) and sodium lauryl sulphate (1·\7 mmolll). The pH of the solvent system was then adjusted to 4·0 with glacial acetic acid.
For identification of the peak assigned to serotonin. HPLC separation was also carried out on a RP-2 column. using solvent systems of l).(ISO molll sodium acetate buffer pH 4·0 with S. III and 20'X, methanol.
ISOI.ATION BY ION-EXCHANGE COLUMNS
Micro isolation columns were prepared in plastic transfer pipettes (Equipment and Services Ltd., Shipley, England) 0·8 cm x l S-S ern, using a slurry of Amberlite CG-50 (1OD-200 mesh) in the NH~form, equilibrated in an ammonium acetate buffer solution 0·20 rnol/l, pH 7·5. The bulbs of the transfer pipettes were cut off, the tips packed to a height of 10 mm and a 2 ml aliquot of 0·02 molll ammonium acetate buffer, pH 7·5, passed through each column. A scheme for the isolation process is depicted in Plasma samples were collected in EDTAcontaining Vacutainers. After gentle inversion the tubes were centrifuged at low speed (500 g, 30 min, 4°C). The platelet-rich plasma was carefully removed with a siliconised pipette and stored on solid CO 2 (according to long-term stability conditions for serotonin advocated by Sasa et at. 3 ) . Prior to analysis (within 1 week after collection) the samples were slowly Start isalation procedure thawed and sonicated for 3 min to disrupt any intact platelet. Then 200 iLl of a mixture consisting of 0·150 ml platelet-rich plasma and 0,150 ml ammonium acetate buffer solution (fHJ2 molll, pH 7·5) which contained 2·H4 iLmolll 5-methoxytryptamine, was applied on a cation-exchange column. The column was subsequently washed with 2·0 ml ammonium acetate buffer O·(J2 mol/l , pH 7·5, and 2·0 ml acetic acid 0·01 moll!. The amines were eluted with 2·0 ml acetic acid solution (I·(l mol/I) with 4% (by weight) ascorbic acid added.
Serum samples were drawn in Vacutainers and allowed to clot spontaneously for 30 min at room temperature. After removal of cells by centrifugation at 3(KKJ g for 15 min (4°C), the serum samples were stored on solid CO:, until analysis (within I week). After thawing a (l·15 ml aliquot was mixed with (l·15 ml of (j.(J2 molll ammonium acetate buffer (pH 7·5) which contained 1·136 iLmol/l 5-methoxytryptamine. and 200 iLL of this mixture was applied on the cation-exchange column. Washing of this micro- Figure 2 illustrates typical chromatograms obtained from serum and platelet-rich plasma. Chromatograms obtained from CSF and urine are depicted in Fig. 3 . Inter-assay accuracy and precision were measured by running duplicate analyses of different physiological fluids (with or without addition of serotonin) for five successive days. Sample aliquots were kept in small vials so that only the required amounts had to be thawed for each analysis. Results are given in Table 2 . Recovery for serotonin in the through the origin, was obtained when serotonin solutions in saline were analysed in the range of 1·1 to 11 nmoi/i. This graph was used in calculating serotonin concentrations in CSF samples.
Mean percentage recoveries for the cationexchange microcolumns were calculated by comparing serotoninlinternal standard fluorescence ratios (in the case of serum, plasma and urine) or serotonin fluorescence only (in the case of CSF) with or without application of the cation-exchange isolation procedure. The results are given in Table 1 . Bovine albumin in saline with 5-HT and 5-MT Saline with 5-HT and 5-MT Saline with 5-HT column and elution of the amines were carried out as outlined for platelet-rich plasma.
Cerebrospinal fluid samples obtained by lumbar puncture were spun at 3500 g for 15 min (4°C) in order to remove all debris. The clear supernatant was carefully removed with a pipette, rapidly frozen and stored in liquid N 2 (for not longer than 1 week). Just before analysis the samples were thawed and a 0·6 ml aliquot added to 0·6 ml of (H12 mol/l ammonium acetate buffer, pH 7·5. One ml of this mixture was transferred to a cation-exchange column. Washing of the column and elution of the amines were performed as presented for platelet-rich plasma.
Aliquots of about 25 ml from 24-hour urine samples were acidified with HCI (6 molll) to pH 2 and stored at 4°C (as advocated for stability conditions for tryptophan metabolites by Geeraerts et at. 4) . Just before analysis (within 1 week after collection) the urine samples were brought to room temperature and spun at 1500 g (15 min, 4°C). A 0·5 ml aliquot was adjusted to (about) pH 7 with ammonium hydroxide solution (20% w/v), mixed with 0·5 ml ammonium acetate buffer (0,02 mollI, pH 7,5) to which 5-methoxytryptamine (568 nmolll) was added and the mixture transferred quantitatively to an ion-exchange column.
Washing of the microcolumn and elution of the amines were carried out as outlined for platelet-rich plasma. CALIBRATION Calibration lines were constructed using 4% (by weight) bovine serum albumin in saline for plasma and serum samples, and saline for urine and cerebrospinal fluid samples. To these solutions varying amounts of serotonin and a constant amount of the internal standard were added, and the mixtures further processed identically as outlined for the different physiological samples. However in the calibration graph for CSF only serotonin was used, omitting 5-methoxytryptamine as internal standard. Analyses were run in duplicate and five data points were used for each calibration graph.
Results and discussion
CALIBRATION GRAPHS
The ratio of fluorescence response of serotonin and internal standard is a linear function over the investigated ranges of serotonin concentration of 57-852, 284-1420 and 568-3409 nmolll, applicable to urine, serum and plasma respectively. Also a linear calibration graph, passing Recent publications demonstrated that 5methoxytryptamine is more widely distributed in mammals than had previously been supposed.v" Measurements by Prozialeck and co-workers' involving selective extraction, derivatization with o-phthalaldehyde, separation of the derivatives by thin-layer chromatography and determination of fluorescence, revealed concentrations of about 5·5 nmol/l in human plasma and urine and a concentration of as high as II nrnol/l in CSF. The results of our experiments did not agree with these findings. Analyses of over lUll different serum and urine samples presented to our laboratory showed the different physiological fluids proved to be quantitative. The day-to-day coefficient of variation was better than 5·5% for platelet-rich plasma, serum or urine, and better than 10% for analyses in CSF. Identification of the peak assigned to serotonin in each of the different pools was based on its chromatographic behaviour. Retention time of this biogenic amine in the samples was identical to those of aqueous standards. HPLC separation of eluates of ion-exchange microcolumns for platelet-rich plasma, serum, urine and CSF samples were also carried out on a RP-2 column, using acetate buffer/methanol solvent systems without SDS. Serotonin always eluted with added serotonin, thus demonstrating the specificity of the method. The detection limit of the procedure is such, that a serotonin concentration in CSF of U·S nrnol/l can be measured with a signal-to-noise ratio of 2.
Serotonin reference intervals measured in blood and urine samples collected from eight male and eight female members of the laboratory personnel, are given in Table 3 . The values of serotonin obtained in serum very well agree with those obtained with radioimmunoassay." For ethical reasons, no reference interval is presented for CSF. Lumbar CSF samples analysed in this study were from neurological patients from whom CSF was being collected during treatment. absence of 5-MT. None of the chromatograms obtained from 12 different serum samples. of a patient with established metastatic carcinoid (followed serially for about 4 months; some serotonin values were as high as 9·1 iLmol/l). showed peaks that could be attributed to 5-MT. We therefore concluded that if present. 5-MT concentrations in serum and urine are too low to be detected at the attenuations routinely used. Our experiments with 25 different CSF samples with serotonin levels in a concentration range from less than 0·5 nmol/I to 5·6 nmol/1. indicated that much lower concentrations for 5-MT existed than was accepted by Prozialeck and co-workers.' The highest concentration estimated in a sample with a serotonin concentration of 5·6 nrnol/l, was only 0·3 nmol/1.
Conclusion
We believe that the present method affords convenience of selectivity and sensitivity superior to other chromatographic and radioimmunoassays of serotonin. 1-. 1.~11l The method proved to be sufficiently sensitive for routine analysis of serotonin in CSF. The chromatograms revealed practically no extraneous peaks. Analysis can be carried out in a short period of time (about 25 min).
